BioLife Solutions, Inc.
BLFS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $95 | $28 | $19 | $70 |
| Short-Term Investments | $9 | $16 | $43 | $0 |
| Receivables | $9 | $19 | $34 | $23 |
| Inventory | $29 | $43 | $35 | $28 |
| Other Curr. Assets | $6 | $14 | $7 | $4 |
| Total Curr. Assets | $149 | $121 | $138 | $126 |
| Property Plant & Equip (Net) | $17 | $33 | $39 | $37 |
| Goodwill | $212 | $225 | $225 | $225 |
| Intangibles | $10 | $21 | $32 | $152 |
| Long-Term Investments | $6 | $13 | $6 | $4 |
| Tax Assets | $0 | $21 | $0 | -$1 |
| Other NC Assets | $6 | -$21 | $9 | $10 |
| Total NC Assets | $251 | $292 | $312 | $427 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $399 | $413 | $450 | $553 |
| Liabilities | – | – | – | – |
| Payables | $4 | $7 | $15 | $15 |
| Short-Term Debt | $12 | $8 | $5 | $4 |
| Tax Payable | $4 | $6 | $5 | $0 |
| Deferred Revenue | $0 | $1 | $1 | $1 |
| Other Curr. Liab. | $12 | $21 | $19 | $23 |
| Total Curr. Liab. | $33 | $42 | $45 | $43 |
| LT Debt | $18 | $26 | $39 | $23 |
| Deferred Rev, NC | $0 | $0 | $0 | -$2 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $5 |
| Other NC Liab. | $0 | $7 | $2 | $5 |
| Total NC Liab. | $18 | $33 | $41 | $32 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14 | $10 | $18 | $20 |
| Total Liabilities | $51 | $75 | $86 | $72 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $1 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$335 | -$313 | -$247 | -$105 |
| AOCI | $0 | -$0 | -$1 | -$0 |
| Other Equity | $684 | $651 | $612 | $585 |
| Total Equity | $349 | $338 | $364 | $481 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $399 | $413 | $450 | $553 |
| Net Debt | -$65 | $6 | $24 | -$43 |